Department of Otolaryngology, Otorhinolaryngology Institute, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology, Otorhinolaryngology Institute, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology, Otorhinolaryngology Institute, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology, Otorhinolaryngology Institute, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;Department of Otolaryngology, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China 在知网中查找 在百度中查找 在本站中查找
Objective To analyze the causative mutation of a nuclear family with autosomal recessive congenital hearing loss. Methods Medical history collection, detailed physical examination and hearing test were performed on the family members. High throughput sequencing was conducted for screening of hearing loss genes. Suspected mutations were analyzed by Sanger sequencing. Results There were 4 people of 2 generations in this family, one member with hearing loss. High throughput sequencing and Sanger sequencing revealed the proband carrying compound heterozygous mutation of MYO7A, NM_000260.3:c.765C>A (p.F255L) from her father and c.275_278dupACCT (p.I94fs) from her mother, and her sister carried the c.765C>A mutation. According to the standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, c.765C>A was classified as likely pathogenic and c.275_278dupACCT classified as pathogenic. Conclusion Novel compound heterozygous mutation of MYO7A is identified as the causative mutation for congenital hearing loss in this family, which enriches the mutation spectrum of MYO7A and provides a basis for genetic counseling of hereditary hearing loss.